These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 12482592)

  • 1. 14-3-3 binding to the IGF-1 receptor is mediated by serine autophosphorylation.
    Parvaresch S; Yesilkaya T; Baer K; Al-Hasani H; Klein HW
    FEBS Lett; 2002 Dec; 532(3):357-62. PubMed ID: 12482592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimerization-induced activation of soluble insulin/IGF-1 receptor kinases: an alternative mechanism of activation.
    Baer K; Al-Hasani H; Parvaresch S; Corona T; Rufer A; Nölle V; Bergschneider E; Klein HW
    Biochemistry; 2001 Nov; 40(47):14268-78. PubMed ID: 11714281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of kinase activity of 3-phosphoinositide-dependent protein kinase-1 by binding to 14-3-3.
    Sato S; Fujita N; Tsuruo T
    J Biol Chem; 2002 Oct; 277(42):39360-7. PubMed ID: 12177059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 14-3-3 proteins interact with the insulin-like growth factor receptor but not the insulin receptor.
    Furlanetto RW; Dey BR; Lopaczynski W; Nissley SP
    Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):765-71. PubMed ID: 9581554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single substitution of the insulin receptor kinase inhibits serine autophosphorylation in vitro: evidence for an interaction between the C-terminus and the activation loop.
    Noelle V; Tennagels N; Klein HW
    Biochemistry; 2000 Jun; 39(24):7170-7. PubMed ID: 10852715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophosphorylation of the insulin-like growth factor I receptor cytoplasmic domain.
    Lopaczynski W; Terry C; Nissley P
    Biochem Biophys Res Commun; 2000 Dec; 279(3):955-60. PubMed ID: 11162456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and functional characteristics of the Val44Met insulin-like growth factor I missense mutation: correlation with effects on growth and development.
    Denley A; Wang CC; McNeil KA; Walenkamp MJ; van Duyvenvoorde H; Wit JM; Wallace JC; Norton RS; Karperien M; Forbes BE
    Mol Endocrinol; 2005 Mar; 19(3):711-21. PubMed ID: 15576456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serine phosphorylation of the insulin-like growth factor I (IGF-1) receptor C-terminal tail restrains kinase activity and cell growth.
    Kelly GM; Buckley DA; Kiely PA; Adams DR; O'Connor R
    J Biol Chem; 2012 Aug; 287(33):28180-94. PubMed ID: 22685298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catalysis of serine and tyrosine autophosphorylation by the human insulin receptor.
    Baltensperger K; Lewis RE; Woon CW; Vissavajjhala P; Ross AH; Czech MP
    Proc Natl Acad Sci U S A; 1992 Sep; 89(17):7885-9. PubMed ID: 1381504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific binding of a 14-3-3 protein to autophosphorylated WPK4, an SNF1-related wheat protein kinase, and to WPK4-phosphorylated nitrate reductase.
    Ikeda Y; Koizumi N; Kusano T; Sano H
    J Biol Chem; 2000 Oct; 275(41):31695-700. PubMed ID: 10918058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of the forkhead in rhabdomyosarcoma (FKHR) phosphorylation sites in regulating 14-3-3 binding, transactivation and nuclear targetting.
    Rena G; Prescott AR; Guo S; Cohen P; Unterman TG
    Biochem J; 2001 Mar; 354(Pt 3):605-12. PubMed ID: 11237865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine residues in the C-terminal domain of the insulin-like growth factor-I receptor mediate mitogenic and tumorigenic signals.
    Esposito DL; Blakesley VA; Koval AP; Scrimgeour AG; LeRoith D
    Endocrinology; 1997 Jul; 138(7):2979-88. PubMed ID: 9202243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosine kinase activity of a chimeric insulin-like-growth-factor-1 receptor containing the insulin receptor C-terminal domain. Comparison with the tyrosine kinase activities of the insulin and insulin-like-growth-factor-1 receptors using a cell-free system.
    Mothe I; Tartare S; Kowalski-Chauvel A; Kaliman P; Van Obberghen E; Ballotti R
    Eur J Biochem; 1995 Mar; 228(3):842-8. PubMed ID: 7737184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct interaction of insulin-like growth factor-1 receptor with leukemia-associated RhoGEF.
    Taya S; Inagaki N; Sengiku H; Makino H; Iwamatsu A; Urakawa I; Nagao K; Kataoka S; Kaibuchi K
    J Cell Biol; 2001 Nov; 155(5):809-20. PubMed ID: 11724822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressor of cytokine signaling (SOCS)-3 protein interacts with the insulin-like growth factor-I receptor.
    Dey BR; Furlanetto RW; Nissley P
    Biochem Biophys Res Commun; 2000 Nov; 278(1):38-43. PubMed ID: 11071852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction in vitro of the product of the c-Crk-II proto-oncogene with the insulin-like growth factor I receptor.
    Koval AP; Blakesley VA; Roberts CT; Zick Y; Leroith D
    Biochem J; 1998 Mar; 330 ( Pt 2)(Pt 2):923-32. PubMed ID: 9480911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of insulin-like growth factor (IGF)-binding protein-3 and its proteolytic fragments on ligand binding, cell surface association, and IGF-I receptor signaling.
    Devi GR; Yang DH; Rosenfeld RG; Oh Y
    Endocrinology; 2000 Nov; 141(11):4171-9. PubMed ID: 11089550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of dual specificity kinase activity of DYRK1A.
    Walte A; Rüben K; Birner-Gruenberger R; Preisinger C; Bamberg-Lemper S; Hilz N; Bracher F; Becker W
    FEBS J; 2013 Sep; 280(18):4495-511. PubMed ID: 23809146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a specific domain responsible for JNK2alpha2 autophosphorylation.
    Cui J; Holgado-Madruga M; Su W; Tsuiki H; Wedegaertner P; Wong AJ
    J Biol Chem; 2005 Mar; 280(11):9913-20. PubMed ID: 15637069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of Raf-1 kinase and protein kinase C zeta in insulin-like growth factor I-induced brown adipocyte mitogenic signaling cascades: inhibition by cyclic adenosine 3',5'-monophosphate.
    Valverde AM; Teruel T; Lorenzo M; Benito M
    Endocrinology; 1996 Sep; 137(9):3832-41. PubMed ID: 8756554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.